The LRRK2 G2019S Mutation Predisposes Parkinson's Disease Patients to Cancer

被引：0
|
作者：
Inzelberg, Rivka
Cohen, Oren S.
Aharon-Peretz, Judith
Schlesinger, Ilana
Yaakov, Zichron
Gershoni-Baruch, Ruth
Djaldetti, Ruth
Nitzan, Zeev
Ephraty, Lilach
Tunkel, Olga
Kozlova, Evgenya
Inzelberg, Lilah
Schechtman, Edna
Kaplan, Natali
Friedman, Eitan
Hassin-Baer, Sharon
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：A17 / A17
页数：1
相关论文
共 50 条
  • [31] G2019S LRRK2 mutation in French and North African families with Parkinson's disease
    Lesage, S
    Ibanez, P
    Lohmann, E
    Pollak, P
    Tison, F
    Tazir, M
    Leutenegger, AL
    Guimaraes, J
    Bonnet, AM
    Agid, Y
    Dürr, A
    Brice, A
    ANNALS OF NEUROLOGY, 2005, 58 (05) : 784 - 787
  • [32] LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease
    Patra, Biswanath
    Parsian, Azemat J.
    Racette, Brad A.
    Zhao, Jing Hua
    Perlmutter, Joel S.
    Parsian, Abbas
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (03) : 175 - 180
  • [33] Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease
    Fung, Hon-Chung
    Chen, Chiung-Mei
    Hardy, John
    Hernandez, Dena
    Singleton, Andrew
    Wu, Yih-Ru
    MOVEMENT DISORDERS, 2006, 21 (06) : 880 - 881
  • [34] The LRRK2 G2019S mutation is a major cause of Parkinson's disease in North Africa
    Lesage, S
    Leutenegger, AL
    Janin, S
    Lohmann, E
    Tazir, M
    Pollak, P
    Durr, A
    Brice, A
    NEUROLOGY, 2006, 66 (05) : A334 - A334
  • [35] G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
    Gaig, Carles
    Marti, Maria Jose
    Ezquerra, Mario
    Rey, Maria Jesus
    Cardozo, Adriana
    Tolosa, Eduardo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (06): : 626 - 628
  • [36] LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease
    Bouhouche, Ahmed
    Tibar, Houyam
    Ben El Haj, Rafiqua
    El Bayad, Khalil
    Razine, Rachid
    Tazrout, Sanaa
    Skalli, Asmae
    Bouslam, Naima
    Elouardi, Loubna
    Benomar, Ali
    Yahyaoui, Mohammed
    Regragui, Wafa
    PARKINSONS DISEASE, 2017, 2017
  • [37] Different origins and demographic histories of the LRRK2 G2019S mutation in Parkinson's disease
    Lesage, S.
    Patin, E.
    Condroyer, C.
    Lentenegger, A-L
    Lohmann, E.
    Pollak, P.
    Ouvrard-Hernandez, A-M
    Bardien-Kruger, S.
    Tomiyama, H.
    Basak, N.
    Durr, A.
    Hattori, N.
    Orr-Urtreger, A.
    Tazir, M.
    Quintana-Murci, L.
    Brice, A.
    MOVEMENT DISORDERS, 2009, 24 : S143 - S143
  • [38] Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
    Guedes, L. Correia
    Ferreira, J. J.
    Rosa, M. M.
    Coelho, M.
    Bonifati, V.
    Sampaio, C.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (04) : 237 - 242
  • [39] Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease
    Kay, Denise M.
    Bird, Tom D.
    Zabetian, Cyrus P.
    Factor, Stewart A.
    Samii, Ali
    Higgins, Donald S.
    Nutt, John
    Roberts, John W.
    Griffith, Alida
    Leis, Berta C.
    Montimurro, Jennifer S.
    Philpott, Sean
    Payami, Haydeh
    GENETIC TESTING, 2006, 10 (03): : 221 - 227
  • [40] Leukocyte MAPK activity associated with the LRRK2 G2019S mutation and Parkinson's disease
    Aasly, J. O.
    Toft, M.
    Farrer, M. J.
    Kvam, S. N.
    White, L. R.
    MOVEMENT DISORDERS, 2006, 21 : S416 - S416
12345